Using modeling to help understand vaginal microbicide functionality and create better products

Drug Delivery and Translational Research

Volumn 1, Issue 3, 2011, Pages 256-276

  Katz, David F ^a   Gao, Yajing ^a   Kang, Meng ^a  

^a Duke University   (United States)

Author keywords

HIV; Mathematical models; Microbicides; Pharmacodynamics; Pharmacokinetics; Vagina

Indexed keywords

CARRAGEENAN; DAPIVIRINE; HYDROXYETHYLCELLULOSE; KY JELLY; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONOXINOL 9; POLYCARBOPHIL; TENOFOVIR; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG TRANSPORT; FILM; GEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROBABILITY; TABLET FORMULATION; VAGINA RING; VIRUS TRANSMISSION;

EID: 84862982218     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-011-0029-z     Document Type: Article

References (72)

1. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996): 1168-74.
2. Nestorov I. Whole body pharmacokinetic models. Clin Pharmacokinet. 2003; 42(10): 883-908.
3. Pang KS, Weiss M, Macheras P. Advanced pharmacokinetic models based on organ clearance, circulatory, and Fractal concepts. AAPS J. 2007; 9(2): E268-83.
4. Saltzman W. Drug delivery: Engineering principles for drug therapy. 1st ed. New York: Oxford University Press; 2001.
5. Avrett S, Harrison P, McGrory E. Mapping the microbicide effort. Silver Spring: Alliance for Microbicide Development; 2007.
6. Geonnotti AR, Katz DF. Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory. Biophys J. 2006; 91(6): 2121-30.
7. Stone A, Harrison PF. Microbicides-ways forward. Silver Spring: Alliance for Microbicide Development; 2010.
8. Geonnotti AR, Katz DF. Compartmental transport model of microbicide delivery by an intravaginal ring. J Pharm Sci. 2010; 99(8): 3514-21.
9. Hendrix CW, Cao YJ, Fuchs EJ. Topical microbicides to prevent HIV: clinical drug development challenges. Annu Rev Pharmacol Toxicol. 2009; 49: 349-75.
10. Mahalingam A, Smith E, Fabian J, Damian FR, Peters JJ, Clark MR, et al. Design of a semisolid vaginal microbicide gel by relating composition to properties and performance. Pharm Res. 2010; 27(11): 2478-91.
11. Tuckwell HC, Shipman PD, Perelson AS. The probability of HIV infection in a new host and its reduction with microbicides. Math Biosci. 2008; 214(1-2): 81-6.
12. Essunger P, Perelson AS. Modeling HIV-infection of CD4(+) T-cell subpopulations. J Theor Biol. 1994; 170(4): 367-91.
13. Kamina A, Makuch RW, Zhao HY. A stochastic modeling of early HIV-1 population dynamics. Math Biosci. 2001; 170(2): 187-98.
14. Merrill SJ. The stochastic dance of early HIV infection. J Comput Appl Math. 2005; 184(1): 242-57.
15. Perelson AS. Modelling viral and immune system dynamics. Nat Rev Immunol. 2002; 2(1): 28-36.
16. Perelson AS, Essunger P, Cao YZ, Vesanen M, Hurley A, Saksela K, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997; 387(6629): 188-91.
17. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996; 271(5255): 1582-6.
18. Phillips AN. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 1996; 271(5248): 497-9.
19. Tan WY, Wu HL. Stochastic modeling of the dynamics of CD4(+) T-cell infection by HIV and some Monte Carlo studies. Math Biosci. 1998; 147(2): 173-205.
20. Tuckwell HC, Le Corfec E. A stochastic model for early HIV-1 population dynamics. J Theor Biol. 1998; 195(4): 451-63.
21. Murray JD. Mathematical biology: I. An introduction. 3rd ed. New York: Springer; 2002.
22. Perelson AS, Kirschner DE, Deboer R. Dynamics of HIV-infection of CD4+ T-cells. Math Biosci. 1993; 114(1): 81-125.
23. Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J. 2009; 11(1): 78-87.
24. Lai BE, Geonnotti AR, Desoto MG, Montefiori DC, Katz DF. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Antiviral Res. 2010; 88(2): 143-51.
25. Jay JI, Shukair S, Langheinrich K, Hanson MC, Cianci GC, Johnson TJ, et al. Modulation of viscoelasticity and HIV transport as a function of pH in a reversibly crosslinked hydrogel. Adv Funct Mater. 2009; 19(18): 2969-77.
26. Lai BE, Henderson MH, Peters JJ, Walmer DK, Katz DF. Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels. Biophys J. 2009; 97(9): 2379-87.
27. Henderson MH, Couchman GM, Walmer DK, Peters JJ, Owen DH, Brown MA, et al. Optical imaging and analysis of human vaginal coating by drug delivery gels. Contraception. 2007; 75(2): 142-51.
28. Mauck CK, Katz D, Sandefer EP, Nasution MD, Henderson M, Digenis GA, et al. Vaginal distribution of Replens and K-Y Jelly using three imaging techniques. Contraception. 2008; 77(3): 195-204.
29. Lai BE. Reduction of HIV-virion transport for prevention of HIV transmission. Durham: Duke University; 2010.
30. Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999; 59(2): 91-5.
31. Plenys AM. Mechanical analysis of topical drug delivery gels for women's reproductive health. Durham: Duke University; 2000.
32. Kieweg SL. Mechanical analysis of vaginal gels intended for microbicide application. Durham: Duke University; 2005.
33. Kieweg SL, Katz DF. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. J Biomech Eng Trans ASME. 2006; 128(4): 540-53.
34. Kieweg SL, Katz DF. Interpreting properties of microbicide delivery gels: analyzing deployment due to squeezing. J Pharm Sci. 2007; 96(4): 835-50.
35. Lai BE, Xie YQ, Lavine ML, Szeri AJ, Owen DH, Katz DF. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J Pharm Sci. 2008; 97(2): 1028-36.
36. Bird RB, Armstrong RC, Hassager O. Dynamics of poylmeric liquids. Volume 1: fluid mechanics. 2nd ed. New York: Wiley; 1987.
37. Leider PJ, Bird RB. Squeezing flow between parallel disks. 1. Theoretical analysis. Ind Eng Chem Fund. 1974; 13(4): 336-41.
38. Sherwood JD, Durban D. Squeeze-flow of a Herschel-Bulkley fluid. J Non-Newtonian Fluid Mech. 1998; 77(1-2): 115-21.
39. Lighthill J. Mathematical biofluiddynamics. Regional Conference Series in Applied Mathematics. Philadelphia: Society for Industrial Mathematics; 1975. pp 1-281.
40. Szeri AJ, Park SC, Verguet S, Weiss A, Katz DF. A model of transluminal flow of an anti-HIV microbicide vehicle: combined elastic squeezing and gravitational sliding. Phys Fluids. 1994; 20(8): 83101. 2008 August.
41. Leal LG. Laminar flow and convective transport processes: scaling principles and asymptotic analysis. Boston: Butterworth-Heinemann; 1992.
42. Minoguchi R, Osborn III TW, Hong H, Owens SJ, Haridas B, inventors. Reverse finite element analysis and modeling of biomechanical properties of internal tissues. US patent 2007/0016391, 18 Jan 2007.
43. Katz D, Peters J, Clark M, Friend D, Kiser P. Multivariate computational model to help rate microbicide gel performance: combining vaginal distribution, drug deliver and acceptability. Pittsburgh: Microbicides 2010.
44. Masters WH, Johnson VE. Human sexual response. Boston: Little Brown; 1966.
45. Mitchell C, Paul K, Agnew K, Gaussman R, Coombs RW, Hitti J. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol. 2011; 49(2): 735-6.
46. Owen DH, Peters JJ, Katz DF. Rheological properties of contraceptive gels. Contraception. 2000; 62(6): 321-6.
47. Crosby BJ, Mangnus M, de Groot W, Daniels R, McLeish TCB. Characterization of long chain branching: dilution rheology of industrial polyethylenes. J Rheol. 2002; 46(2): 401-26.
48. Peppas NA. Physiologically responsive hydrogels. Journal of Bioactive and Compatible Polymers. 1991; 6(3): 241-6.
49. Podual K, Doyle F, Peppas NA. Modeling of water transport in and release from glucose-sensitive swelling-controlled release systems based on poly(diethylaminoethyl methacrylate-g-ethylene glycol). Ind Eng Chem Res. 2004; 43(23): 7500-12.
50. Szeri A, Tasoglu S, Park S, Gao Y, Katz D. Biophysical computation of vaginal dilution and distribution of microbicide gels. Pittsburgh: Microbicides 2010.
51. Szeri AJ, Tasoglu S, Katz DF. Transport processes in vaginal films that release anti-HIV microbicide molecules. Annual meeting of the Biophysical Society, Baltimore; 2011.
52. Katz DF, Henderson MH, Owen DH, Plenys AM, Walmer DK. What is Needed to Advance Vaginal Formulation Technology? In: Rencher WF, editor. Vaginal microbicide formulations workshop. Philadelphia: Lippincott-Raven; 1998. p. 90-9.
53. Kheyfets VO, Kieweg SL. Free-surface coating flows of non-Newtonian gels: 3-D numerical simulation of gravity-induced flow. In: Proceeding of the Asme Summer Bioengineering Conference; 2007. pp 531-532.
54. Barnhart KT, Izquierdo A, Pretorius ES, Shera DM, Shabbout M, Shaunik A. Baseline dimensions of the human vagina. Hum Reprod. 2006; 21(6): 1618-22.
55. Skalak R, Ozkaya N, Skalak TC. Biofluid mechanics. Annu Rev Fluid Mech. 1989; 21: 167-204.
56. Grotberg JB, Jensen OE. Biofluid mechanics in flexible tubes. Annu Rev Fluid Mech. 2004; 36: 121-47.
57. Pedley TJ. The fluid mechanics of large blood vessels. New York: Cambridge University Press; 1980.
58. Barnhart KT, Pretorius ES, Shera DM, Shabbout M, Shaunik A. The optimal analysis of MRI data to quantify the distribution of a microbicide. Contraception. 2006; 73(1): 82-7.
59. Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception. 2004; 70(6): 498-505.
60. Barnhart KT, Pretorius ES, Shaunik A, Timbers K, Nasution M, Mauck C. Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2. 5 and 3. 5 mL). Contraception. 2005; 72(1): 65-70.
61. Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D. Distribution of a 3. 5-mL (1. 0%) C31G vaginal gel using magnetic resonance imaging. Contraception. 2005; 71(5): 357-61.
62. Buckheit RW, Watson KM, Morrow KM, Ham AS. Development of topical microbicides to prevent the sexual transmission of HIV. Antivir Res. 2010; 85(1): 142-58.
63. Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2010; 14(5): 1124-36.
64. McGowan I. Microbicides for HIV prevention: reality or hope? Curr Opin Infect Dis. 2010; 23(1): 26-31.
65. Chen J, Katz DF. Compartmental analysis of intravaginal HIV transport and neutralization by microbicides. Annual meeting of the Biophysical Society, Baltimore; 2011.
66. Buckheit RW, Watson K, Fliakas-Boltz V, Russell J, Loftus TL, Osterling MC, et al. SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. Antimicrob Agents Chemother. 2001; 45(2): 393-400.
67. Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS, Rohan LC, et al. Vaginal microbicide gel for the delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrobial Agents and Chemotherapy 2011; (in press).
68. International Rectal Microbicide Advocates. From promise to product: advancing rectal microbicide research and advocacy. In: The 2010 International Microbicides Conference; 2010.
69. Minces LR, McGowan I. Advances in the development of microbicides for the prevention of HIV infection. Current Infectious Disease Reports. 2010; 12(1): 56-62.
70. Drake T, Rinehart M, Kim KH, LaCroix J, Henderson M, DeSoto M, et al. Simultaneous optical detection of intravaginal gel coating, dilution, drug distribution and tissue integrity in women. Pittsburgh: Microbicides; 2010.
71. Szeri A, Tasoglu S, Park S, Gao Y, Katz D, editors. Biophysical computation of vaginal dilution and distribution of microbicide gels. Pittsburgh: Microbicides; 2010.
72. Kieweg SL, Witelski TP, Katz DF, editors. Free-surface coating flows of non-Newtonian vaginal gels: numerical and experimental simulations of gravity-induced flow. In: American Society of Mechanical Engineering Summer Bioengineering Conference, Amelia Island; 2006.